FLAVIVIRUS PROTEASE SUBSTRATES AND INHIBITORS
    2.
    发明申请
    FLAVIVIRUS PROTEASE SUBSTRATES AND INHIBITORS 审中-公开
    FLAVIVIRUS PROTEASE底物和抑制剂

    公开(公告)号:US20080032917A1

    公开(公告)日:2008-02-07

    申请号:US11619155

    申请日:2007-01-02

    摘要: The invention provides substrate specificity profiles for flaviviral proteases (e.g., dengue proteases or West Nile protease). Optimal flaviviral protease substrate sequences, both to the prime side and non-prime side of the flaviviral protease recognition site, are disclosed herein. The flaviviral protease substrate sequences are used in designing substrates, inhibitors, and prodrugs. Flaviviral protease inhibitors based on substrate specificity are also provided.

    摘要翻译: 本发明提供黄病毒蛋白酶(例如登革热蛋白酶或西尼罗河蛋白酶)的底物特异性谱。 本文公开了黄病毒蛋白酶识别位点的最优侧和非质量侧的最佳黄病毒蛋白酶底物序列。 黄病毒蛋白酶底物序列用于设计底物,抑制剂和前药。 还提供了基于底物特异性的黄病毒蛋白酶抑制剂。

    Methods of identifying modulators of human retrovirus replication
    3.
    发明申请
    Methods of identifying modulators of human retrovirus replication 失效
    鉴定人类逆转录病毒复制调节剂的方法

    公开(公告)号:US20060171923A1

    公开(公告)日:2006-08-03

    申请号:US10849567

    申请日:2004-05-18

    IPC分类号: A61K48/00 C12Q1/70

    CPC分类号: C12Q1/6897 C12Q1/702

    摘要: This invention relates to the discovery that the transcription factors Pbx1 and HMG1 are involved in retrovirus, e.g., HIV, replication. Thus, the invention provides methods of identifying modulators of these proteins. Such modulators can be used as reagents in in vitro assays to modulate expression of retroviral sequences and may be used to inhibit HIV replication in vivo.

    摘要翻译: 本发明涉及转录因子Pbx1和HMG1参与逆转录病毒例如HIV复制的发现。 因此,本发明提供鉴定这些蛋白质的调节剂的方法。 这种调节剂可用作体外测定中的试剂以调节逆转录病毒序列的表达,并可用于抑制体内HIV复制。

    Methods for the synthesis of substituted purines
    4.
    发明申请
    Methods for the synthesis of substituted purines 审中-公开
    合成取代嘌呤的方法

    公开(公告)号:US20060009642A1

    公开(公告)日:2006-01-12

    申请号:US11223429

    申请日:2005-09-09

    IPC分类号: C07D473/24 C07D473/16

    摘要: The invention provides general methods for preparing 2,9-, 2,6,9-, O6-aryl- and O6-alkyl-substituted purines in a combinatorial and traceless fashion. The methods involve, in some embodiments, Mitsunobu alkylation of 2-fluoro-6-phenylsulfenylpurine at N9 with alcohols in solution, followed by C2-capture of the purine core with a resin-bound amine and subsequent oxidation and displacement of the C6 sulfonyl group with amines and anilines.

    摘要翻译: 本发明提供了一种制备组合中的2,9-,2,6,9-六-O-芳基和O-6 - 烷基取代的嘌呤的一般方法, 无痕的时尚。 在一些实施方案中,所述方法涉及N9上的2-氟-6-苯基亚磺酰基嘌呤在溶液中的醇的Mitsunobu烷基化,随后用树脂结合的胺C2-捕获嘌呤核心,随后氧化和置换C6磺酰基 与胺和苯胺。

    Differential tag length analysis of cell proliferation
    6.
    发明申请
    Differential tag length analysis of cell proliferation 审中-公开
    差异标签长度分析细胞增殖

    公开(公告)号:US20050009052A1

    公开(公告)日:2005-01-13

    申请号:US10830708

    申请日:2004-04-22

    CPC分类号: G01N33/5011

    摘要: The present invention is based on a novel cell tagging approach called “Differential Tag Length” method (DTLA) that allows the quantitative analysis of a mixture of multiple cell types (e.g., strains) grown in very small cultivation volumes. DTLA can also be fully automated and adapted for a high-throughput format. The invention provides methods for detecting proliferation of a mixture of cell types in a culture, for screening a library of compounds to identify those compounds that modulate proliferation of a cell, and for detecting the presence or absence of targets in a sample. The invention also provides kits comprising at least first polynucleotide tag and a second polynucleotide tag.

    摘要翻译: 本发明基于称为“差异标签长度”(DTLA)的新型细胞标记方法,其允许定量分析以非常小的培养体积生长的多种细胞类型(例如菌株)的混合物。 DTLA也可以完全自动化并适应高吞吐量格式。 本发明提供了用于检测培养物中细胞类型混合物的增殖的方法,用于筛选化合物文库以鉴定调节细胞增殖的那些化合物,以及用于检测样品中靶标的存在或不存在。 本发明还提供了包含至少第一个多核苷酸标签和第二个多核苷酸标签的试剂盒。